VEEV Quote, Financials, Valuation and Earnings

Schrodinger has a net margin of 30.06% compared to Veeva Systems's net margin of -100.43%. Veeva Systems's return on equity of 14.13% beat Schrodinger's return on equity of -43.06%.

Veeva Systems has a consensus price target of $291.65, signalling upside risk potential of 2.65%. On the other hand Schrodinger has an analysts' consensus of $31.78 which suggests that it could grow by 21.61%. Given that Schrodinger has higher upside potential than Veeva Systems, analysts believe Schrodinger is more attractive than Veeva Systems.

Veeva Systems has a beta of 0.990, which suggesting that the stock is 1.04% less volatile than S&P 500. In comparison Schrodinger has a beta of 1.633, suggesting its more volatile than the S&P 500 by 63.305%.

Veeva Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Schrodinger offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Veeva Systems pays -- of its earnings as a dividend. Schrodinger pays out -- of its earnings as a dividend.

Veeva Systems quarterly revenues are $759M, which are larger than Schrodinger quarterly revenues of $59.6M. Veeva Systems's net income of $228.2M is higher than Schrodinger's net income of -$59.8M. Notably, Veeva Systems's price-to-earnings ratio is 60.20x while Schrodinger's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Veeva Systems is 16.47x versus 8.26x for Schrodinger. Usually stocks with elevated PS ratios are considered overvalued.

Simulations Plus has a net margin of 30.06% compared to Veeva Systems's net margin of 13.7%. Veeva Systems's return on equity of 14.13% beat Simulations Plus's return on equity of 3.97%.

Veeva Systems has a consensus price target of $291.65, signalling upside risk potential of 2.65%. On the other hand Simulations Plus has an analysts' consensus of $42.00 which suggests that it could grow by 54.3%. Given that Simulations Plus has higher upside potential than Veeva Systems, analysts believe Simulations Plus is more attractive than Veeva Systems.

Veeva Systems has a beta of 0.990, which suggesting that the stock is 1.04% less volatile than S&P 500. In comparison Simulations Plus has a beta of 0.973, suggesting its less volatile than the S&P 500 by 2.692%.

Veeva Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Simulations Plus offers a yield of 0.88% to investors and pays a quarterly dividend of $0.06 per share. Veeva Systems pays -- of its earnings as a dividend. Simulations Plus pays out 48.18% of its earnings as a dividend. Simulations Plus's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Veeva Systems quarterly revenues are $759M, which are larger than Simulations Plus quarterly revenues of $22.4M. Veeva Systems's net income of $228.2M is higher than Simulations Plus's net income of $3.1M. Notably, Veeva Systems's price-to-earnings ratio is 60.20x while Simulations Plus's PE ratio is 77.77x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Veeva Systems is 16.47x versus 7.03x for Simulations Plus. Usually stocks with elevated PS ratios are considered overvalued.

Nano Mobile Healthcare has a net margin of 30.06% compared to Veeva Systems's net margin of --. Veeva Systems's return on equity of 14.13% beat Nano Mobile Healthcare's return on equity of --.

Veeva Systems has a consensus price target of $291.65, signalling upside risk potential of 2.65%. On the other hand Nano Mobile Healthcare has an analysts' consensus of -- which suggests that it could fall by --. Given that Veeva Systems has higher upside potential than Nano Mobile Healthcare, analysts believe Veeva Systems is more attractive than Nano Mobile Healthcare.

Veeva Systems has a beta of 0.990, which suggesting that the stock is 1.04% less volatile than S&P 500. In comparison Nano Mobile Healthcare has a beta of -1.077, suggesting its less volatile than the S&P 500 by 207.685%.

Veeva Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nano Mobile Healthcare offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Veeva Systems pays -- of its earnings as a dividend. Nano Mobile Healthcare pays out -- of its earnings as a dividend.

Veeva Systems quarterly revenues are $759M, which are larger than Nano Mobile Healthcare quarterly revenues of --. Veeva Systems's net income of $228.2M is higher than Nano Mobile Healthcare's net income of --. Notably, Veeva Systems's price-to-earnings ratio is 60.20x while Nano Mobile Healthcare's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Veeva Systems is 16.47x versus -- for Nano Mobile Healthcare. Usually stocks with elevated PS ratios are considered overvalued.

Xsovt Brands has a net margin of 30.06% compared to Veeva Systems's net margin of --. Veeva Systems's return on equity of 14.13% beat Xsovt Brands's return on equity of --.

Veeva Systems has a consensus price target of $291.65, signalling upside risk potential of 2.65%. On the other hand Xsovt Brands has an analysts' consensus of -- which suggests that it could fall by --. Given that Veeva Systems has higher upside potential than Xsovt Brands, analysts believe Veeva Systems is more attractive than Xsovt Brands.

Veeva Systems has a beta of 0.990, which suggesting that the stock is 1.04% less volatile than S&P 500. In comparison Xsovt Brands has a beta of 7.457, suggesting its more volatile than the S&P 500 by 645.693%.

Veeva Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xsovt Brands offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Veeva Systems pays -- of its earnings as a dividend. Xsovt Brands pays out -- of its earnings as a dividend.

Veeva Systems quarterly revenues are $759M, which are larger than Xsovt Brands quarterly revenues of --. Veeva Systems's net income of $228.2M is higher than Xsovt Brands's net income of --. Notably, Veeva Systems's price-to-earnings ratio is 60.20x while Xsovt Brands's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Veeva Systems is 16.47x versus -- for Xsovt Brands. Usually stocks with elevated PS ratios are considered overvalued.